According to the University of Utah Pharmacy Services website, which tracks drug shortages in the US, Camber Pharmaceuticals and Sun Pharma are reporting Adderall supply problems. In addition to the recent problems, nine providers of the drug have been having difficulties meeting demand since 2019. To make the problem worse, Adderall is classified as a Schedule 2 controlled substance so companies have limits on how much they can manufacture.
Click here to read the entire article.